slides · global inventory
Image
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 119,566
Current window 81,781-81,810
Pages 3,986
Rows per page 30
Component
81,781-81,810 of 119,566
17
The slide uses a two-column layout to contrast product development/contracts with regulatory compliance.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
19
AMMO | Investor Presentation Deck | 27 slidesAMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
21
AMMO | Investor Presentation Deck | 27 slidesAMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
22
AMMO | Investor Presentation Deck | 27 slidesAMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
23
AMMO | Investor Presentation Deck | 27 slidesAMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
24
Describes a corporate spin-off/divestiture process.AMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
27
AMMO | Investor Presentation Deck | 27 slidesAMMO | Investor Presentation Deck | 27 slides · AMMO, Inc.
Pitch deck Investor relations 1 hit
01
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
02
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
03
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
04
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
05
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
06
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
07
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
09
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)1 hit
11
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
13
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction1 hit
14
Uses a before-after visual comparison to explain the mechanism of action.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
18
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
19
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
34
Includes a smaller inset chart comparing current data to prior 50/100 mg dose data.Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations Beat · Solution (Provide relief)1 hit
50
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
52
Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slidesAnebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides · Anebulo Pharmaceuticals
Conference presentation Investor relations 1 hit
01
Includes company logo, date, and ticker symbol.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
08
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit
10
The slide uses a diagram of an antibody to map specific functional regions to their biological mechanisms.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · SolutionLoop · Golden Circle1 hit
12
The slide uses a simple additive framework to show how immune response and clinical activity lead to a strategic positioning as a 'backbone' therapy.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
16
The slide uses a before-and-after medical imaging comparison to validate clinical efficacy.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
18
Includes a timeline of biopsy (Bx) and treatment, and paired dot plots showing pre/post treatment changes in CD68+ and CD3+ cell counts.Apexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations Beat · Traction1 hit
21
Apexigen | Investor Presentation Deck | 27 slidesApexigen | Investor Presentation Deck | 27 slides · Apexigen
Pitch deck Investor relations 1 hit